ArticleJCO precision oncology2021

FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience.

Jennifer J Gile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.